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Abstract
Context: Publication bias jeopardizes evidence-based medicine, mainly through biased literature syntheses. Publication bias
may also affect laboratory animal research, but evidence is scarce.
Objectives: To assess the opinion of laboratory animal researchers on the magnitude, drivers, consequences and potential
solutions for publication bias. And to explore the impact of size of the animals used, seniority of the respondent, working in
a for-profit organization and type of research (fundamental, pre-clinical, or both) on those opinions.
Design: Internet-based survey.
Setting: All animal laboratories in The Netherlands.
Participants: Laboratory animal researchers.
Main Outcome Measure(s): Median (interquartile ranges) strengths of beliefs on 5 and 10-point scales (1: totally
unimportant to 5 or 10: extremely important).
Results: Overall, 454 researchers participated. They considered publication bias a problem in animal research (7 (5 to 8)) and
thought that about 50% (32–70) of animal experiments are published. Employees (n = 21) of for-profit organizations
estimated that 10% (5 to 50) are published. Lack of statistical significance (4 (4 to 5)), technical problems (4 (3 to 4)),
supervisors (4 (3 to 5)) and peer reviewers (4 (3 to 5)) were considered important reasons for non-publication (all on 5-point
scales). Respondents thought that mandatory publication of study protocols and results, or the reasons why no results were
obtained, may increase scientific progress but expected increased bureaucracy. These opinions did not depend on size of
the animal used, seniority of the respondent or type of research.
Conclusions: Non-publication of ‘‘negative’’ results appears to be prevalent in laboratory animal research. If statistical
significance is indeed a main driver of publication, the collective literature on animal experimentation will be biased. This
will impede the performance of valid literature syntheses. Effective, yet efficient systems should be explored to counteract
selective reporting of laboratory animal research.
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Introduction
Publication bias jeopardizes evidence-based medicine through
biased literature syntheses of clinical studies. [1,2] It is conceivable
that non-publication practices affect laboratory animal research
too.[3–6] In particular, non-reporting of ‘‘negative’’ research
findings may hamper progress in laboratory animal research
(LAR) through unnecessary duplications of experiments and may
lead to premature first-in-man studies. Data on the extent of non-
publication in LAR is scarce.[7–10] Historically, the outlook on
publishing may be different between clinical and laboratory animal
research. For example, in his book ‘Introduction a` l’e´tude de la
medicine experimentale’, the founding father of experimental
physiology, Claude Bernard, argued that ‘‘[.] in physiology we must
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never make average descriptions of experiments because the true relations of
phenomena disappear in the average; [.] we must [.] present our most perfect
experiment as a type’’. [11] More recently, Lemon and Dunnett,
arguing against the use of systematic reviews for LAR, wrote that ‘‘no
mechanism exists for so called negative results to be published. [.]. This is not just
an issue of publication bias [.]. Scientific experiments are designed to test for
evidence in favour of a particular experimental hypothesis and to abandon it if
insufficient evidence is acquired.’’ [12] Against this background, we
assessed laboratory animal researchers’ opinions about magnitude,
drivers, consequences and potential solutions for publication bias in
Table 1. Summary responses to a survey among Dutch experimental animal researchers.
Question{ Scale N"
Median
(p25–p75)
6. Overall, what % of ethics-approved experiments performed in experimental animal
research is published?
0–100% 454 50 (32–70)
7. Overall, what % of animal experiments you have been involved in have been published on? 0–100% 2151 80 (60–90)
8. Do you consider publication bias a problem for experimental animal research? 1–10 (not at all - extremely) 448 7 (5–8)
9. What are important causes of non-publication in experimental animal research? 1–5 (totally unimportant - very important) 444
1. Lack of statistically significant differences (‘‘negative’’ findings) 4 (4–5)
2. Instrumentation/technical problems 4 (3–4)
3. Lack of time to write manuscripts 2 (2–3)
4. Loss of interest 2.5 (2–3)
5. Many studies are seen as pilot studies only 3 (3–4)
10. Who are responsible for non-publication in experimental animal research? 1–5 (least important - most important) 440
1. Senior researchers (supervisors) 4 (3–5)
2. Junior researchers (research fellow/PhD) 3 (2–4)
3. Editors 4 (3–4)
4. Reviewers/Referees 4 (3–5)
5. Funders 2 (1–4)
11. Publication bias is important for experimental animal research with respect to: 1–10 (totally unimportant – extremely
important)
434
1. Duplication of research efforts 8 (7–9)
2. Bias in literature reviews or meta-analyses 8 (7–9)
3. Initiation of phase-1 clinical trials in humans 7 (6–8)
12. Would you use initiatives to make the publishing of negative results or comments
on why an experiment could not be completed much easier, for example an (anonymous)
online database or (online) journals of negative result?
1–3 (1 = never, 2 = sometimes, 3 = often/
always)
432 2 (2–3)
14. Mandatory anonymous publication of research protocols of all ethics-approved animal
research experiments in a publically available database would change:
1–5 (extreme increase - extreme decrease) 426
1. Duplication of research efforts 4 (3–4)
2. Validity of literature reviews 2 (2–3)
3. Certainty that competing investigators do not catch up 3 (3–4)
4. Bureaucracy 2 (1–3)
5. Overall scientific progress 2 (2–3)
Question Scale N Median
(p25–p75)
15. Mandatory anonymous publication of a brief structured form in a publically available
database, that gave main results or explained why an experiment could not be completed
would change:
1–5 (extreme increase - extreme decrease) 423
1. Duplication of research efforts 4 (3–4)
2. Validity of literature reviews 2 (2–3)
3. Certainty that competing investigators do not catch up 3 (3–4)
4. Bureaucracy 2 (2–3)
5. Overall scientific progress 2 (2–3)
{Questions are numbered according to the survey in which questions 1 to 5 enquired after respondents’ background characteristics (Appendix S2).
"Between 17 March and 30 July 2011, 474 laboratory animal researchers returned the survey. Fifty-one respondents did not fill in the survey completely. Of these, we
excluded 20 because of absence of (at least) their background data. The variation in the total number of 454 respondents across table 1 is caused by the other 31
respondents.
1The group that (co-)authored 0–5 studies was excluded from this row because very junior investigators very often had either zero or 100 percent of their papers
publish.
doi:10.1371/journal.pone.0043404.t001
Publication Bias in Laboratory Animal Research
PLOS ONE | www.plosone.org 2 September 2012 | Volume 7 | Issue 9 | e43404
The Netherlands (575,278 animals used in experiments in 2010)
[13]. We explored the impact of animal size, researcher seniority,
working in a for-profit organization and type of research on those
opinions.
Methods
We approached respondents via a two-step procedure: (i) the
Dutch professional association of animal welfare officers, and (ii)
all animal welfare officers. In March 2011, we sent a standard
letter of invitation to participate by email to all animal welfare
officers in the Netherlands via one liaison person (ML) who had
access to them through their professional association. Since the
animal welfare officers have address lists of all researchers that
(had) performed LAR in their institutes, they were asked to send
the invitation letter to all their animal researchers. The invitation
letters (Appendix S1) contained the link to the internet-based
survey and explained that confidentiality was guaranteed for the
respondent and their institute. In the months prior to the survey’s
launch, two authors (GtR and LH) had secured informal
commitment to the survey from animal welfare officers in ten
institutes.
The survey (Appendix S2) addressed five background features:
(i) field of expertise, (ii) affiliation, (iii) size of the animals used
[small (e.g. birds, rodents, fish, amphibians, reptiles) versus large
(otherwise) or both], (iv) seniority of the respondent, as expressed
by the number of (co-)authored publications, and (v) the type of the
research of the respondent, where we defined pre-clinical research
as LAR to investigate if a drug, procedure or treatment may have
an effect in humans; other research was deemed basic. These
background variables were also used in one-way stratified analyses
to assess if results varied by these variables. The estimates for the
publication rates were analyzed using bootstrapped quantile
regression (200 repetitions) to adjust for the simultaneous effects
of the four stratification variables. Items were scored on 5 or 10
point scales, in which 1 indicated totally unimportant and 5 or 10
extremely important.
We used Surveymonkey software (www.surveymonkey.com)
and STATA software (version 10.1). Mann-Whitney and Kruskal-
Wallis tests (in combination with Tukey’s post-hoc test) were used
to assess statistical significance (alpha = 0.05). We applied the
Bonferroni correction to adjust for multiple testing.
Results
Through the Dutch professional association of animal welfare
officers, all animal welfare officers (n = 39) received the invitation
letter and an internet link for the survey. We estimate that between
2,000 and 3,500 laboratory animal researchers received the
invitation to participate. Between 17 March and 30 July 2011, 474
(between 14–24%) laboratory animal researchers returned the
survey. Fifty-one respondents did not fill in the survey completely.
Of these, we excluded 20 because of absence of (at least) their
background data. This left 454 participants for the analysis. The
variation in the number of respondents across table 1 is caused by
the other 31 respondents.
Table 1 shows the main results. Table S1 shows the results
stratified by four background variables. On average, those working
in not-for-profit institutes (n = 421) estimated that 50 percent
(interquartile range (IQR) 35 to 70) of all conducted laboratory
animal experiments are published. Researchers in a for-profit
environment (n = 21) estimated that only 10 percent (5 to 50) is
published. Researchers in not-for-profit institutes reported that 80
percent (60 to 90) of their own work had been published against 10
percent (5 to 39) of the work of researchers in a for-profit
environment. Respondents working only with large animals
thought that their own work was published in 90 percent of cases
(79 to 100) against 75 percent (50 to 90) for those working with
small animals only. Results from the multivariable analyses change
these results only slightly (Tables S2 and S3). In particular,
respondents who had co-authored more than 5 papers estimated
publication rates 10 percentage points higher than respondents
who had published less (95% CI from 0.8 to 19.1). Respondents
working with large animals only estimated the publication rate of
work they had been involved in personally 10 percentage points
higher (95% CI from 1.1 to 18.9). Statistical non-significance and
technical problems are considered to be the main drivers for non-
publication. Supervisors, editors, and reviewers were considered
responsible for non-publication. As expected, funders were
considered more important in a for-profit environment (2 versus
4). Overall, respondents considered publication bias an important
problem for LAR (7 (IQR 5–8)) and for research duplication,
literature syntheses and well-timed initiation of phase-1clinical
trials in humans in particular. Table 1 shows that respondents
thought mandatory publication of study protocols or results may
help avoid unnecessary duplication, increase validity of literature
syntheses and scientific progress, but at the cost of increased
bureaucracy. These opinions did not depend on size of the animal
used, seniority of the respondent or type of research.
Discussion
Publication bias is an important problem in laboratory animal
research (LAR) according to laboratory animal researchers. We
estimate that only fifty percent of LAR is published, but it may be
far less in for-profit organizations given that their employees
estimated that only ten percent of LAR gets published overall,
including their own. Lack of statistical significance, technical
problems, the opinions of supervisors and peer reviewers were
considered important drivers of non-publication. Respondents
thought that mandatory publication of study protocols, research
results or the reasons why results could not be obtained may
accelerate scientific progress.
To our knowledge, this is the first survey among laboratory
animal researchers focusing on publication bias. This survey has
several limitations. First, we estimate the response rate to this
survey to be between 14 and 24 percent. We do not know to which
extent the results are representative for the Dutch LAR
community, let alone for the wider LAR community. The number
of laboratory animal researchers in The Netherlands is unknown.
We were unable to obtain exact information from the institutes on
to the number of E-mail addresses to which the survey had been
sent. Another difficulty is that such address lists may not always be
fully up to date. In particular, researchers who retire or change
jobs may be listed in error. Second, the survey was restricted to
one country. Third, only few researchers in for-profit organiza-
tions participated. Fourth, our results are reminiscent of the joke
about surveys on driving ability in which 90% of respondents think
that they belong to the group of people whose driving abilities are
above-average. Likewise, it seems somewhat paradoxical that our
respondents estimate the publication rate of their own work as
much higher (in theory, they could have calculated it) than the
overall rate. Another explanation may be that the 50% rate
mentioned in the introduction to the survey acted as an anchor
that made respondents estimate the overall rates as too low. That
would imply that a non-publication rate of 20% is closer to the
truth. This issue is related to the next one. Fifth, our study
investigated researchers’ opinions, which may not reflect the true
rate(s) of non-publication. Sixth, due to the large number of
Publication Bias in Laboratory Animal Research
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statistical significance tests (n = 121), application of the Bonferroni
correction for multiple testing (at alpha= 0.05) implies that only p-
values below 0.0004 should be considered statistically significant
(see also the legend to Table S1). The assessment of the effects of
the four stratification variables should be considered explorative.
Seventh, we were unable to assess the impact of scientific sub-
discipline on the results since the free text field (survey item A.1,
Appendix S2) yielded imprecise data with large variation.
Data on non-publication rates in LAR are scarce. Sena et al,
using the statistical ‘‘trim and fill’’ technique on a large number of
animal experiments on acute ischemic stroke, estimated the non-
publication rate to be 13.6 percent which was associated with a
30% overstatement of efficacy. [6] Evidence from clinical research
on humans suggests that between 46 and 67 percent of studies are
not published [14–17], and that in those published, positive
findings are over-emphasized. [18,19] The emergence of trial
registration, and the joint statement of the International Commit-
tee of Medical Journal Editors on publication of randomized trials
being conditional on a trial having a public trial registration
number may have reduced these numbers. [20] We agree with
Sena et al who argued that ‘‘non-publication is unethical since it
deprives researchers of the accurate data they need to estimate the
potential of novel therapies in clinical trials, but also because the
included animals are wasted because they do not contribute to
accumulating knowledge. In addition, research syntheses that
overstate effects may lead to further unnecessary animal experi-
ments testing poorly founded hypotheses.’’ [6].
Measures against the suppression of ‘‘negative’’ results can be
categorized from the source, via upstream to more downstream
measures. Since, in The Netherlands, all experiments must pass a
Institutional Animal Care and Use Committee (IACUC) for ethics
approval, IACUCs may play a crucial role in the registration of all
LAR and prevention of publication bias. A system ensuring
periodic follow-up of each experiment’s fate would reinforce such
registration. It may be challenging to build a watertight system
that simultaneously minimizes bureaucracy. Application of mod-
ern information technology may be crucial. One option to prevent
that study results have an effect on the editorial decision is to
initially submit manuscripts without any results. [21] Editors and
peer reviewers would judge the importance of submissions through
the background, hypotheses and methods sections. This would
ensure that acceptance is not conditional on the results. More
downstream measures include special journals, journal sections or
repositories for ‘‘negative’’ results, such as the Journal of Negative
Results in Biomedicine, The All Results Journals and Negative
Results in Gynecological Oncology. [4,22,23] In addition, two
journals, the Journal of Cerebral Blood Flow and Metabolism and
Neurobiology of Aging, feature Negative Results sections with a
very similar flavor. [24,25] The Journal of Cerebral Blood Flow
and Metabolism describes this section as follows: ‘‘Negative
Results is intended to provide a forum for data that did not
substantiate [.] a difference between the experimental groups,
and/or did not reproduce published findings. Since the net effect
of a Negative Result is to discourage repetition, the standards for
acceptance as a Negative Result will be highly demanding.
Typically, Type II error considerations are mandatory.’’ [24].
Statistical significance testing is probably a main driver of non-
publication. This is especially unfortunate given the widespread
errors involved in understanding the meaning of p-values.[26–28].
What are the implications for further research? As we have
learnt from randomized trials in humans, follow-up of cohorts of
study protocols may help us understand the magnitude and the
causes of publication bias in LAR, which in turn may affect the
research community’s motivation to deal with it. In the meantime,
more research into statistical correction of publication bias seems
useful.[29–31] Specifically, the comparison of various methods to
deal with publication bias statistically, such as the trim and fill
[32], regression-based methods [30,33,34], and capture-recapture
[31] may be compared in simulation studies to assess their
strengths and weaknesses in various situations.
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